Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01801735 · ClinicalTrials.gov registry record · Phase 3
Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip
A Phase 3 study, sponsored by Iroko Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 600
- Enrollment target
NCT01801735 is a Phase 3 study that has completed, run by Iroko Pharmaceuticals. The registered enrollment target is 600 participants.
The verdict
NCT01801735, a Phase 3 study, has completed, sponsored by Iroko Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 600 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety of Meloxicam SoluMatrix Capsules for up to 52 weeks in subjects with pain due to osteoarthritis (OA) of the knee or hip
Interventions
- DRUG Meloxicam Test Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01801735
The ClinicalTrials.gov registry entry for NCT01801735 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iroko Pharmaceuticals, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Meloxicam Test Capsules is the first listed.
NCT01801735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01801735 about?
NCT01801735 is a clinical study titled "Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip". The purpose of this study is to evaluate the safety of Meloxicam SoluMatrix Capsules for up to 52 weeks in subjects with pain due to osteoarthritis (OA) of the knee or hip
What is the current status of trial NCT01801735?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 600 participants. The study started on 2013-03. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01801735?
The interventions under investigation include: Meloxicam Test Capsules (DRUG).
Who is sponsoring clinical trial NCT01801735?
This trial is sponsored by Iroko Pharmaceuticals, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.